Literature DB >> 15211654

A novel missense mutation in the galactosyltransferase-I (B4GALT7) gene in a family exhibiting facioskeletal anomalies and Ehlers-Danlos syndrome resembling the progeroid type.

Muhammad Faiyaz-Ul-Haque1, Syed Hassan Ejaz Zaidi, Mariam Al-Ali, Mariam S Al-Mureikhi, Shelley Kennedy, Ghalia Al-Thani, Lap-Chee Tsui, Ahmad Said Teebi.   

Abstract

The Ehlers-Danlos syndrome (EDS) is a heterogeneous group of heritable connective tissue disorders characterized by skin hyperextensibility, joint hypermobility, and tissue fragility. Several genes have been implicated to result in EDS phenotypes. The progeroid type of EDS is characterized by wrinkled, loose skin on the face, curly fine hair, scanty eyebrows and eyelashes, in addition to the classical features of EDS. Here we describe two similarly affected individuals in two sibships of a large consanguineous family from Qatar. DNA samples from affected and unaffected members of the family were analyzed for homozygosity of polymorphic markers associated with genes that have been implicated in EDS. Among 28 markers analyzed, homozygosity was only observed for D5S469 and D5S2111, which were markers for galactosyltransferase-I (B4GALT7) located on chromosome 5q35.2, where the previously reported progeroid-like variant of EDS has been mapped. Exons harboring the coding regions and exon-intron junctions of B4GALT7 were amplified by PCR and examined for mutations. A homozygous misssense C to T substitution at nucleotide 808 in the coding region was discovered in both affected individuals. The carrier parents were heterozygous for this mutation, which was not found among 76 DNA samples from control individuals of the same ethnicity. Segregation of this novel mutation in the family further confirmed the allelic variant and its recessive mode of inheritance in this type of EDS. The C to T substitution results in an arginine to cysteine change at amino acid residue 270 that is located in the catalytically active extracellular C-terminal domain. This change could result in abnormal protein folding and/or aberrant interactions of mutated galactosyltransferase-I with other extracellular matrix proteins leading to the development of a progeroid-like phenotype in affected individuals. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15211654     DOI: 10.1002/ajmg.a.30005

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  37 in total

1.  Clinical utility gene card for: B4GALT7-defective congenital disorder of glycosylation.

Authors:  Jaak Jaeken; Dirk J Lefeber; Gert Matthijs
Journal:  Eur J Hum Genet       Date:  2016-11-09       Impact factor: 4.246

2.  Expanding the clinical spectrum of B4GALT7 deficiency: homozygous p.R270C mutation with founder effect causes Larsen of Reunion Island syndrome.

Authors:  François Cartault; Patrick Munier; Marie-Line Jacquemont; Jeannine Vellayoudom; Bérénice Doray; Christine Payet; Hanitra Randrianaivo; Jean-Marc Laville; Arnold Munnich; Valérie Cormier-Daire
Journal:  Eur J Hum Genet       Date:  2014-04-23       Impact factor: 4.246

3.  A decorin-deficient matrix affects skin chondroitin/dermatan sulfate levels and keratinocyte function.

Authors:  Katerina Nikolovska; Jana K Renke; Oliver Jungmann; Kay Grobe; Renato V Iozzo; Alina D Zamfir; Daniela G Seidler
Journal:  Matrix Biol       Date:  2014-01-18       Impact factor: 11.583

Review 4.  Golgi glycosylation and human inherited diseases.

Authors:  Hudson H Freeze; Bobby G Ng
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-09-01       Impact factor: 10.005

5.  Skeletal dysplasia in a consanguineous clan from the island of Nias/Indonesia is caused by a novel mutation in B3GAT3.

Authors:  Birgit S Budde; Shuji Mizumoto; Ryo Kogawa; Christian Becker; Janine Altmüller; Holger Thiele; Franz Rüschendorf; Mohammad R Toliat; Gerrit Kaleschke; Johannes M Hämmerle; Wolfgang Höhne; Kazuyuki Sugahara; Peter Nürnberg; Ingo Kennerknecht
Journal:  Hum Genet       Date:  2015-04-19       Impact factor: 4.132

6.  Faulty initiation of proteoglycan synthesis causes cardiac and joint defects.

Authors:  Sevjidmaa Baasanjav; Lihadh Al-Gazali; Taishi Hashiguchi; Shuji Mizumoto; Bjoern Fischer; Denise Horn; Dominik Seelow; Bassam R Ali; Samir A A Aziz; Ruth Langer; Ahmed A H Saleh; Christian Becker; Gudrun Nürnberg; Vincent Cantagrel; Joseph G Gleeson; Delphine Gomez; Jean-Baptiste Michel; Sigmar Stricker; Tom H Lindner; Peter Nürnberg; Kazuyuki Sugahara; Stefan Mundlos; Katrin Hoffmann
Journal:  Am J Hum Genet       Date:  2011-07-15       Impact factor: 11.025

Review 7.  Redefining the progeroid form of Ehlers-Danlos syndrome: report of the fourth patient with B4GALT7 deficiency and review of the literature.

Authors:  Michael H Guo; Joan Stoler; Julian Lui; Ola Nilsson; Diana W Bianchi; Joel N Hirschhorn; Andrew Dauber
Journal:  Am J Med Genet A       Date:  2013-08-16       Impact factor: 2.802

8.  Defective glycosylation of decorin and biglycan, altered collagen structure, and abnormal phenotype of the skin fibroblasts of an Ehlers-Danlos syndrome patient carrying the novel Arg270Cys substitution in galactosyltransferase I (beta4GalT-7).

Authors:  Daniela G Seidler; Muhammad Faiyaz-Ul-Haque; Uwe Hansen; George W Yip; Syed H E Zaidi; Ahmad S Teebi; Ludwig Kiesel; Martin Götte
Journal:  J Mol Med (Berl)       Date:  2006-04-01       Impact factor: 4.599

Review 9.  Syndecans in cartilage breakdown and synovial inflammation.

Authors:  Thomas Pap; Jessica Bertrand
Journal:  Nat Rev Rheumatol       Date:  2012-10-23       Impact factor: 20.543

Review 10.  Human genetic disorders caused by mutations in genes encoding biosynthetic enzymes for sulfated glycosaminoglycans.

Authors:  Shuji Mizumoto; Shiro Ikegawa; Kazuyuki Sugahara
Journal:  J Biol Chem       Date:  2013-03-01       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.